Identification |
Name: | Benzoic acid,4-(acetylamino)- |
Synonyms: | Benzoicacid, p-acetamido- (6CI,7CI,8CI);4-(Acetylamino)benzoic acid;4-Acetamidobenzoic acid;4'-Carboxyacetanilide;Acedoben;N-Acetyl-p-aminobenzoicacid;NSC 4002;p-(Acetoamino)benzoic acid;p-(Acetylamino)benzoic acid;p-Acetamidobenzoic acid;p-Acetaminobenzoic acid; |
CAS: | 556-08-1 |
EINECS: | 209-114-7 |
Molecular Formula: | C9H9NO3 |
Molecular Weight: | 179.17 |
InChI: | InChI=1/C9H9NO3/c1-6(11)10-8-4-2-7(3-5-8)9(12)13/h2-5H,1H3,(H,10,11)(H,12,13) |
Molecular Structure: |
|
Properties |
Density: | 1.326 g/cm3 |
Stability: | Stable. Combustible. Incompatible with strong oxidizing agents. |
Water Solubility: | | <0.1 g/100 mL at 21 ºC |
Solubility: | <0.1 g/100 mL at 21 ºC in water |
Appearance: | White to beige in colour crystalline powder |
Specification: | white or off-white powder or crystals Safety Statements:24/25 24/25:Avoid contact with skin and eyes |
HS Code: | 29242995 |
Storage Temperature: | Keep container closed when not in use. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. |
Usage: | Used for the enhancement of the immune response in patients with persistent generalised lymphadenopathy at risk of developing acquired immunodeficiency syndrome (aids). |
Safety Data |
|
|